Could an Alpaca’s monoclonal antibodies be used to treat an ultra-rare blood disease?
Ablynx's Nanobody platform has used the smaller than human monoclonal antibodies from an alpaca to…
Ablynx's Nanobody platform has used the smaller than human monoclonal antibodies from an alpaca to…
UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial…
Thanks to Alexion Pharmaceuticals, two ultra-rare diseases finally got the first treatment in the European Union,…
New success for Newron Pharmaceuticals. The FDA approved Orphan Drug designation to its new chemical…
The European Medicines Agency (EMA) is about to approve a couple of rare diseases drugs…
Alexion Pharmaceuticals will travel across the ocean to build its first ever biologics manufacturing facility outside…
Wilson Therapeutics has closed a €37.4M Series B financing to advance its late-stage development program for…
AOP Orphan Pharmaceuticals and Confluence Pharmaceuticals, signed today a definitive agreement to co-develop and market…
Baxter has acquired SuppreMol for €200M before working capital and other adjustments. The acquisition includes…
Researchers in Barcelona have developed a shuttle to transport drugs into the brain, running through the…